#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in intestine Follicle centre lymphoma follicular grade I II – III refractory Adenocarcinoma gastric Transferrin decreased Follicular lymphoma stage III Aplastic anaemia Systemic scleroderma Pericarditis Cryoglobulinaemia Desmoid tumour Desmoplastic small round cell tumour Noonan syndrome Orthostatic hypotension Castleman's disease Hepatic cirrhosis More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Basic Information Hepatic angiosarcoma Piriformis syndrome – Basic Information Encephalitis autoimmune – Trials in Disease Hereditary motor and sensory neuropathy Advanced systemic mastocytosis – Life with Disease Brain stem glioma – Diagnostics Shprintzen-Goldberg syndrome – Diagnostics Factor VIII deficiency Mucopolysaccharidosis I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Autologous Chondrocytes Formoterol Fumarate Dihydrate Tebentafusp SODIUM HYDROXIDE ANTI-GD2-800CW SODIUM SULFIDE NONAHYDRATE Ticagrelor Air, Medicinal Valproic Acid GS-4321 Imgn151 Lenzumestrocel O15-Water Osilodrostat Metformin Embonate Zipalertinib AUR200 Diazepam Acetylcysteine Mva-209-Fsp-B3 More therapies…

    Learn about Your Condition

    Paget's disease of the vulva Systemic mastocytosis Carotid artery occlusion Renal failure Angiosarcoma Ocular melanoma Ovarian cancer metastatic Malignant neoplasm of choroid Mitochondrial myopathy Left ventricular dysfunction Solitary fibrous tumour Upper limb fracture Alveolar bone defect Retroperitoneal fibrosis Dyslipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Tislelizumab
    Italy

  • Long-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Axicabtagene Ciloleucel
    Austria Belgium France Germany Italy The Netherlands +1

  • Study on Luspatercept for Improving Brain Oxygenation in Patients with Non-Transfusion Dependent Thalassemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thalassaemia beta
    • Thalassaemia
    Investigated Drugs:
    • Luspatercept
    The Netherlands

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Alteplase
    Germany Ireland The Netherlands Poland Spain

  • Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valganciclovir
    • Letermovir
    France
Previous Page
1 … 550 551 552 553 554 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!